Summary
  • Multi-target molecules 197
  • Clinical molecules 0
  • Avg pChEMBL 7.1
Top Co-occurrence Targets
Active Molecules (197)
InChIKey pChEMBL Type Targets Clinical
GTLDPUSOCDSHIU 6.3 IC50 2
GZWRFHALZSJWCL 6.3 IC50 2
HOGIUARUHFASKN 6.3 IC50 2
HWBPESUHQMIXLB 6.3 IC50 2
IPGMAZLYVSWCJD 6.3 IC50 2
JCPOHWPGDQUOQN 6.3 IC50 2
JLZPYUNNWVRLGQ 6.3 IC50 2
JLZPYUNNWVRLGQ 6.3 IC50 2
JSAQCZWEOZMZCG 6.3 IC50 2
KAPDZTAMKBHBAC 6.3 IC50 2
KRNGPDUFHQXSOZ 6.3 IC50 2
LSFMSEYLICBQLD 6.3 IC50 2
LSFMSEYLICBQLD 6.3 IC50 2
LUMXDKZMUPIRHM 6.3 IC50 2
LVLPBPSLLDDHMK 6.3 IC50 2
MMOGDCKWHZFLMO 6.3 IC50 2
MRSXETXDOITHNK 6.3 IC50 2
MVMXSHQQBNAWMC 6.3 IC50 2
OYEOCKYUCQUKMH 6.3 IC50 2
OYEOCKYUCQUKMH 6.3 IC50 2
QFWWLRCXQIIMLA 6.3 IC50 2
QJDMARSQHXLLBE 6.3 IC50 2
RCFGNCPIHMGBGF 6.3 IC50 2
RFISFJYBBQQZPY 6.3 IC50 2
RUJRCMWJRKOZTO 6.3 IC50 2
SIQVSLICJZAZGM 6.3 IC50 2
UEGSTNJPMSGHMF 6.3 IC50 2
VQJHSXBJTLPKHO 6.3 IC50 2
VVXBKZFYMWTAHG 6.3 IC50 2
VYYDFJQUXALHPF 6.3 IC50 2
VYYDFJQUXALHPF 6.3 IC50 2
XHWLSZIPRUJMBX 6.3 IC50 2
XHWLSZIPRUJMBX 6.3 IC50 2
YCSCOAGMDRJISW 6.3 IC50 2
ZSSDZVMVWPPHTJ 6.3 IC50 2
ZZNLHLJRATZLSO 6.3 IC50 2
QLWOSILDDBBNKU 6.2 Ki 2
ZPEDAVGOVRCNQR 6.2 IC50 2
FMPUADOXTPMTON 6.2 IC50 2
MKZYMKKUBVPEET 6.2 Ki 2
RXNNWOBJWBKPHT 6.2 IC50 2
JZRRCGQQCZGHEA 6.1 IC50 2
HZTJOSBNLNQPCX 6.1 IC50 2
WBLZKCOFIDSWKH 6.1 Kd 2
YIEPOGUSSKXXSP 6.1 Ki 2
XCUCLKWBHWYCEZ 6.1 Kd 2
LIENCHBZNNMNKG 6.1 Ki 2
2D structure